Motley Fool5g fa · leggi qui →
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet.
Cathie Wood is loading up on shares of a biotech that could be one of the first entrants to the psychedelics market.…
Stocktwits7g fa · leggi qui →
CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today – Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners
Wells Fargo began coverage on five biotech stocks on Monday, with only Compass Pathways receiving an ‘Equal-Weight’ rating while the rest received ‘Overweight’ ratings.…
IPO-Edge.com12g fa · leggi qui →
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
Watch Fireside Chat Below, or Click HERE: IPO Edge hosted a fireside chat with Jupiter Neurosciences, Inc. (Nasdaq: JUNS) Chairman, Chief Executive Officer and Co-founder Christer Rosén and Alison Sil…
Proactive17g fa · leggi qui →
Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Phase II analysis distinguishes the company’s psychological support approach from psychotherapy, …
MT Newswires17g fa · leggi qui →
European Equities Traded in the US as American Depositary Receipts Decline Friday
European equities traded in the US as American depositary receipts were lower on Friday morning, she…
Simply Wall St.17g fa · leggi qui →
COMPASS Pathways (CMPS) Is Down 8.6% After Phase 3 Durability Data For COMP360 In TRD
Earlier in July 2026, COMPASS Pathways reported 26-week data from its second Phase 3 COMP006 trial of COMP360 psilocybin in treatment-resistant depression, showing rapid onset, durable clinical benefi…
Motley Fool18g fa · leggi qui →
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion
Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments.…
MT Newswires18g fa · leggi qui →
European Equities Traded in the US as American Depositary Receipts Edge Lower Thursday
European equities traded in the US as American depositary receipts were slightly lower on Thursday m…
Investing.com18g fa · leggi qui →
Why Psychedelic stocks are surging today
Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting…
Stocktwits18g fa · leggi qui →
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too?
Both ATAI and CMPS stocks were among the top trending on Stocktwits in pre-market trade.…